Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Myeloproliferative Disorders 2Myelodysplastic Syndromes 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Acute 2Polycystic Ovary Syndrome 1Myelodysplastic-Myeloproliferative Diseases 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Insulin Resistance 1Inflammation 1Hyperandrogenism 1Congenital Abnormalities 1Anovulation 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Metformin 30Exercise 8Pioglitazone 7Inositol 6Insulin 4Acupuncture Therapy 4High-Intensity Interval Training 3Ethinyl Estradiol 3salicylsalicylic acid 2drospirenone and ethinyl estradiol combination 2Water 2Tablets 2Sugars 2Resistance Training 2Preoperative Exercise 2Folic Acid 2Diet Therapy 2Cyproterone Acetate 2Caloric Restriction 2Biguanides 2ziprasidone 1maltodextrin 1lime 1licogliflozin 1exendin (9-39) 1drospirenone 1cinnulin PF 1adrenosterone 1Zoledronic Acid 1World Health Organization oral rehydration solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Insulin Resistance × Sodium Salicylate × Clear all
NCT03229408 2025-06-10

TIN-PCOS-AOD

University of Illinois at Chicago

Phase 2 Completed
60 enrolled 28 charts

Anovulation, Inflammation, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡